Skip to content

A Comparative Study on the Clinical Efficacy and Mechanisms of Calorie-Restricted Balanced Diet and Folic Acid Therapy in Overweight/Obese Patients with Hyperhomocysteinemia

A Comparative Study on the Clinical Efficacy and Mechanisms of Calorie-Restricted Balanced Diet and Folic Acid Therapy in Overweight/Obese Patients with Hyperhomocysteinemia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119661
Enrollment
Unknown
Registered
2026-03-02
Start date
2025-06-30
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight/Obesity Hyperhomocysteinemia

Interventions

Calorie-Restricted Balanced Diet (CRD) Intervention Group:Calorie-Restricted Balanced Diet Protocol
Folic Acid Supplementation Group:Low-dose folic acid therapy (0.8 mg/d) with habitual diet

Sponsors

The People's Hospital of Ningxia Hui Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Aged 18-65 years old 2) BMI: 24.0-40.0 kg/m^2 3) Hcy >=10 µmol/L 4) Had not taken any supplements or medications that may reduce blood homocysteine concentration for at least 1 month before the study began 5) Voluntarily participated in the study, signed the Informed Consent Form, and were able to comply with the protocol

Exclusion criteria

Exclusion criteria: 1) Pregnant or lactating women 2) Suffering from thyroid diseases or any type of cancer; with chronic kidney disease (GFR < 60 mL/min/1.73 m^2) 3) Suffering from severe diseases such as cardiovascular and cerebrovascular diseases, hepatic and renal insufficiency, malignant tumors, etc. 4) Scheduled to have any disease requiring hospitalization within the next 3 months 5) Using anti-inflammatory or immunosuppressive drugs, weight-loss drugs, having food allergies or intolerance to any dietary components, or following a vegetarian diet 6) Unable to complete the questionnaire or unsuitable for this study for other reasons

Design outcomes

Primary

MeasureTime frame
Homocysteine;Weight;Inflammatory Cytokines;Metabolic Parameters;

Secondary

MeasureTime frame
Dietary Inflammatory Index (DII);Body Composition;Gut Microbiota Sequencing;

Countries

China

Contacts

Public ContactZhao Qian

The People's Hospital of Ningxia Hui Autonomous Region

18995160125@163.com+86 189 9516 0125

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026